After-Hours Stock Movers:

IVERIC bio, Inc. (Nasdaq: ISEE) 22% HIGHER; announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for avacincaptad pegol (ACP, also known as Zimura®), a novel investigational complement C5 inhibitor for the treatment of geographic atrophy (GA) secondary to Age-Related Macular Degeneration (AMD).

Ross Stores (NASDAQ: ROST) 15% HIGHER; reported Q3 EPS of $1.00, $0.19 better than the analyst estimate of $0.81. Revenue for the quarter came in at $4.57 billion versus the consensus estimate of $4.36 billion. Ross Stores sees Q4 2023 EPS of $1.13-$1.26, versus the consensus of $1.13. Ross Stores sees FY2023 EPS of $4.21-$4.34, versus the consensus of $4.01

Gap, Inc. (NYSE: GPS) 10% HIGHER; reported Q3 EPS of $0.71, $0.71 better than the analyst estimate of $0.00. Revenue for the quarter came in at $4.04 billion versus the consensus estimate of $3.81 billion.

Williams-Sonoma (NYSE: WSM) 8% LOWER; reported Q3 EPS of $3.72, $0.01 worse than the analyst estimate of $3.73. Revenue for the quarter came in at $2.19 billion versus the consensus estimate of $2.15 billion.

Ardelyx (NASDAQ: ARDX) 7% HIGHER; Director, David Mott, bought 567,000 shares on 11/17/22 at $1.7648.

Palo Alto Networks (NASDAQ: PANW) 6% HIGHER; reported Q1 EPS of $0.83, $0.14 better than the analyst estimate of $0.69. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.55 billion. Palo Alto Networks sees Q2 2023 EPS of $0.76-$0.78, versus the consensus of $0.71. Palo Alto Networks sees Q2 2023 revenue of $1.63-1.66 billion, versus the consensus of $1.65 billion. Palo Alto Networks sees FY2023 EPS of $3.37-$3.44, versus the consensus of $3.17. Palo Alto Networks sees FY2023 revenue of $6.85-6.91 billion, versus the consensus of $6.87 billion.

Applied Materials (NASDAQ: AMAT) 3% HIGHER; reported Q4 EPS of $2.03, $0.28 better than the analyst estimate of $1.75. Revenue for the quarter came in at $6.75 billion versus the consensus estimate of $6.45 billion. Applied Materials sees Q1 2023 EPS of $1.75-$2.11, versus the consensus of $1.83. Applied Materials sees Q1 2023 revenue of $6.3-7.1 billion, versus the consensus of $6.45 billion.